This article, published in the Bulletin de la Société de Pathologie Exotique, summarizes an international conference held in Niamey, Niger, that brought together more than 100 delegates to assess the current meningitis situation in Africa, …

This web page provides regular updates on meningococcal disease outbreaks around the world as reported to the World Health Organization. It also serves as an archive, housing links to outbreak news alerts dating back to 1999.

This article, published in The Lancet Infectious Diseases, provides an overview of a systematic review and meta-analysis of published papers from 1998 to 2008 to estimate the risks of major and minor sequelae caused by bacterial meningitis,  …

This article, published in the journal Vaccine, reviews meningococcal disease epidemiology and its variability across geographic area and time. The review summarizes the current status of meningococcal disease epidemiology by region, but notes that …

This article, published in the Pediatric Infectious Disease Journal, reviews outbreaks of meningococcal disease across the globe and the serotypes associated with these outbreaks. The author also discusses the different vaccines …

The Global Meningococcal Initiative (GMI) is composed of an international group of scientists, clinicians, and public health officials that aim to promote the global prevention of invasive meningococcal disease through education and research. In …

This fact sheet describes the model employed by the Meningitis Vaccine Project to develop a safe, affordable, and long-lasting vaccine to combat Group A meningococcal epidemics in Africa, as well as the contributions of the key partners who made the …

This article, published in the Journal of Experimental Medicine, discusses a study in the United States that suggests that natural immunity to meningococcal disease is initiated, reinforced, and broadened by intermittent carriage of different …

This article, published in the Journal of Experimental Medicine, provides a reinvestigation of the immunogenicity in human beings of the meningococcal group A and C antigens based on previous studies of the molecular weights of these polysaccharides …

This article, published in the Journal of Experimental Medicine, describes a new method for the isolation of the meningococcal group-specific polysaccharides that make it possible to produce highly purified group A and group C polysaccharides.

This article, published in the Journal of Experimental Medicine, discusses a small-scale field trial that was carried out in United States military recruits to test the effect of immunization with meningococcal C polysaccharide upon the …

This article, published in the Journal of Experimental Medicine, reviews an earlier study of the age-specific incidence of meningococcal meningitis in the United States that found that the proportion of individuals with serum bactericidal …

Currently, no explanation exists for the epidemic pattern of meningitis in the African meningitis belt, in spite of recent progress in disease surveillance. Such a model would be conducive to mathematically mapping vaccine strategies or predicting …

This article, published in the journal Vaccine, discusses a study of 42 Gambian children revaccinated at age five with meningococcal A/C polysaccharide vaccine (MPS) after receiving two doses of MPS in infancy and either MPS, meningococcal A/C …

This site offers information on vaccine and immunization programs at the American Academy of Pediatrics and includes video and text resources for parents. Resources include frequently asked questions for families, immunization information for …

This partnership of nongovernmental, professional, health, consumer, government, and private-sector organizations aims to promote the understanding and use of vaccines recommended by Canada's National Advisory Committee on Immunization. Its goal is …

This article, published in The New England Journal of Medicine, discusses the methods and results of two studies conducted in Africa to evaluate a new meningococcal A conjugate vaccine. The conclusion of the studies is that the new vaccine has a …

This article, published in Vaccine, describes a study that compared the immunogenicity and safety of a single dose of a new meningococcal A conjugate vaccine (PsA-TT, MenAfriVac™, Serum Institute of India Ltd.) against the meningococcal group …

This web page provides links to individual disease/vaccine-specific modules that are intended to give immunization managers and vaccination professionals a brief and easy-to-understand overview of the scientific basis of vaccination, as well as the …

This article, published in the Journal of Infectious Diseases, investigates the impact of meningococcal serogroup C conjugate vaccine introduction in the United Kingdom on asymptomatic carriage of meningococci to establish whether …

The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1 to 29-year-olds in Burkina Faso in 2010. The authors of this article, published in Clinical Infectious …

This poster, presented at the 2008 International Pathogenic Neisseria Conference, displays the results of a study to determine the effectiveness of the Standard Operating Procedures that were developed in 2001 to 2002 to codify and enhance …

Although existing conjugate vaccines protect against some types of bacterial meningitis, new vaccines are needed to broaden protection against the disease. Published in Current Opinion in Neurology, this article posits new uses for existing vaccines …

This article, published in AIDS, describes a cohort surveillance study conducted in South Africa to compare the incidence of meningococcal disease among HIV-infected individuals versus uninfected individuals. The authors also evaluated the extent to …

This fact sheet outlines PATH's work on vaccines and immunization. Topic areas include developing affordable vaccines, designing innovative vaccine technologies, and expanding uptake of existing vaccines. These efforts reduce the burden of malaria, …